Abhilasha Singh: Proteomics and the New Science of Cardiovascular Aging
Abhilasha Singh, Review Editor at Frontiers in Stroke, Reviewer at Springer Nature Phytomedicine, Frontiers in Neurology and AHA, shared a post on LinkedIn:
“We are beginning to measure aging — not just describe it.
At the heart of discussions aligned with ESC 2026, one theme is becoming increasingly clear: proteomics is redefining how we understand cardiovascular aging.
Large-scale studies now show that aging is not uniform – instead, individuals exhibit distinct ‘ageotypes’, shaped by circulating protein signatures linked to inflammation, metabolism, and vascular biology.
What is particularly striking is the ability of plasma proteomics to:
- Capture organ-specific aging signals
- Identify senescence-associated proteins in circulation
- Predict cardiovascular risk even before clinical disease manifests
This reframes aging from a passive process to something that is:
- measurable
- system-wide
- biologically dynamic
In many ways, the blood proteome is emerging as a functional readout of aging biology – a ‘liquid map’ of cardiovascular risk.
For those of us working at the intersection of inflammation, lipid biology, and aging, this feels like a natural evolution of earlier questions – now approached with far greater resolution.
The future of cardiovascular medicine may lie not only in treating disease, but in quantifying and modulating biological aging itself.”

Stay updated with Hemostasis Today.
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology
-
Sep 23, 2026, 13:04Ben Samelson-Jones: Do Gene Variants Drive PK Differences in FIX-Fusion and N9-GP Therapies?
-
Sep 23, 2026, 12:57Shelly Reed: Advocating for HTCs and CDC Funding with the Hemophilia Federation of America